Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Aurora Cannabis Inc.

ACBNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.75
$-0.02(-0.53%)
U.S. Market opens in 13h 56m

Aurora Cannabis Inc. (ACB) Stock Overview

Explore Aurora Cannabis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap207M
P/E Ratio7.01
EPS (TTM)$-1.09
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$1.18
3 Months$5.30
1 Year Target$5.35

ACB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aurora Cannabis Inc. (ACB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.01 and a market capitalization of 207M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.18%
5-Day Change
1.39%
1-Month Change
-17.61%
3-Month Change
-13.30%
6-Month Change
-26.85%
Year-to-Date (YTD) Change
-15.90%
1-Year Change
-34.94%
3-Year Change
-58.05%
5-Year Change
-96.74%
All-Time (Max) Change
-96.63%

Contact Information

16043625207
500 - 10355 Jasper Avenue, Edmonton, AB, T5J 1Y6

Company Facts

10,730 Employees
IPO DateJul 15, 2014
CountryCA
Actively Trading

Frequently Asked Questions